Cancer Stage

Natural Cancer Supplement: Cell Forte with IP-6 and Inositol by Enzymatic Therapy

Tue, 13 Feb 2007 07:47:09 +0100

Cell Forte with IP-6 is a unique combination of inositol and inositol hexaphosphate (IP-6). Together, inositol and IP-6 create a remarkable increase in natural killer cell activity and enhances natural cellular defenses. Both inositol and IP-6 are found naturally in the cells of the body. However, studies show that by supplementing with Cell Forte, the cells become stronger.

Bayer ends cancer trial after good survival results

Tue, 13 Feb 2007 01:25:59 +0100

Bayer and Onyx Pharmaceuticals have ended a late stage trial of Nexavar after analysis of the trial showed that the drug extended survival rates in patients with liver cancer.

Presented By

Tue, 13 Feb 2007 01:25:59 +0100

Onyx shares rise on liver-cancer drug news

Mon, 12 Feb 2007 20:44:39 +0100

Shares of Emeryville-based Onyx Pharmaceuticals Inc. more than doubled Monday after the company reported favorable late-stage trial results for a liver cancer treatment.

Presented By

Mon, 12 Feb 2007 20:44:39 +0100

Mayor battles cancer again

Mon, 12 Feb 2007 19:13:26 +0100

Prostate ailment wont hamper campaign plan. Mayor Darwin Hindman said he has been diagnosed with early-stage prostate cancer, but he already has begun treatment and expects a full recovery by this spring.

Presented By

Mon, 12 Feb 2007 19:13:26 +0100

Mayor battling prostate cancer

Mon, 12 Feb 2007 16:13:06 +0100

Mayor Darwin Hindman says hes been diagnosed with early-stage prostate cancer but that hes already begun treatment he expects to fully recover by this spring.

Presented By

Mon, 12 Feb 2007 16:13:06 +0100

Kaisers Play Teenage Cancer Trust Gig

Mon, 12 Feb 2007 16:41:05 +0100

Subtitle The band are the final big act in the star-studded line-up... Subject Matter Kaiser Chiefs Body 'Ruby'rabblerousersKaiser Chiefshave announced they will complete the line-up at this year'sTeenage Cancer Trustgigs at the Royal Albert Hall. The Chiefs will take to the stage on Friday, March 30, with support fromGruff RhysandThe Cribs . They will join a ...

Presented By

Mon, 12 Feb 2007 16:41:05 +0100

Onyx shares soar on liver cancer drug study

Mon, 12 Feb 2007 22:33:48 +0100

Drugmaker says it will seek approval for Nexavar as liver cancer treatment after it prolonged lives of patients.

Presented By

Mon, 12 Feb 2007 22:33:48 +0100

Onyx's Liver-Cancer Drug Blew Away Trial Goals

Mon, 12 Feb 2007 19:18:50 +0100

Onyx's liver-cancer drug proved overwhelmingly effective in late-stage testing.

Presented By

Mon, 12 Feb 2007 19:18:50 +0100

Onyx Shares Zoom on Cancer-Drug News

Mon, 12 Feb 2007 20:06:20 +0100

The company and partner Bayer ended trials of Nexavar early after data showed the drug's efficacy in treating liver cancer

Presented By

Mon, 12 Feb 2007 20:06:20 +0100

New cancer drugs may save 1,300 lives a year, tests show

Tue, 13 Feb 2007 08:04:35 +0100

An extra 1,300 lives a year could be saved in the UK if all women with breast cancer were given new drugs that deprive the tumour of oxygen, research suggests today.

Presented By

Tue, 13 Feb 2007 08:04:35 +0100

Lung Cancer Alliance Hails Veterans Service Organizations' Call For Early Lung Cancer Detection Program

Tue, 13 Feb 2007 07:05:28 +0100

Lung Cancer Alliance (LCA) today hailed veterans service organizations for calling on Congress to fund a lung cancer early detection pilot program specifically for veterans at high risk for lung cancer. LCA President Laurie Fenton called the request "ground-breaking. [click link for full article]

Presented By

Tue, 13 Feb 2007 07:05:28 +0100

British Journal of Urology Demonstrates Ablatherm Success for Late Stage Prostate Cancer Therapy.

Italian Study Shows Up to 90% Efficacy at 12 Months in Stage T2b and T3 High Risk Patients LYON, France, Feb. 5 /PRNewswire-FirstCall/ - EDAP TMS S.A. , the global leader in High Intensity Focused Ultrasoundtreatment of prostate cancer, reports a recent publication outlines successful ...

Presented By

Canadian Women With Node-Positive Early-Stage Breast Cancer to Benefit From Newly Approved Chemotherapy Treatment With Conditions

- Health Canada's Conditional Approval of New Post-Surgical Therapy, Taxotere in combination with doxorubicin and cyclophosphamide, Provides Women an Added Treatment Option and Hope - LAVAL, QC, Jan. 24 /CNW/ - Canadian women diagnosed with node-positive early-stage breast cancer now have a new ...

Presented By

Cancer Care Concerns Early-Stage Breast Cancer Patients Who Are Obese or Less Educated Are More Likely to Be Treated With Lower Chemo Doses, Study Says

Women in the early stages of breast cancer are at high risk of receiving sub-optimal treatment based on their weight or education, according to a new study out of the University of Rochester Medical Center. Even as the American Cancer Society reported this week that cancer death rates declined for ...

Presented By

GSK drug could work on early-stage cancers.

Byline: Sabine Vollmer Jan. 3-New test results suggest that a GlaxoSmithKline drug awaiting regulatory approval to treat late-stage breast cancer also has potential to corral the disease early on, before tumors spread. Scientists who studied Tykerb in women unresponsive to other therapies ...

Presented By

Lapatinibto be Evaluated in Early Stage Disease in Adjuvant Breast Cancer Settings Internationally.

First Global Trial Investigates Lapatinib in Adjuvant Settings to Assess Impact in Early Stage Disease PHILADELPHIA and BOSTON, Dec. 13 /PRNewswire/ - GlaxoSmithKline and Massachusetts General Hospital Cancer Center today announced the initiation of a landmark international breast cancer clinical ...

Presented By

FDA expands use of Herceptin for early stage breast cancer after primary therapy.

M2 PRESSWIRE-17 November 2006-US FDA: FDA expands use of Herceptin for early stage breast cancer after primary therapy1994-2006 M2 COMMUNICATIONS LTD RDATE:16112006 The U. S. Food and Drug Administrationtoday expanded the approved use of Herceptin, a biological cancer drug. The new ...

New Study Shows InSure Colorectal Cancer Screening Test Significantly Better at Detecting Early Stage Colorectal Cancers Compared to Traditional Test.

The InSure Test Should Help Reduce Colorectal Cancer Mortality and Incidence LYNDHURST, N.J., Nov. 2 /PRNewswire-FirstCall/ - A study published in the journal CANCER found that InSure, a Fecal Immunochemical Testfrom Quest Diagnostics Incorporated detected three times as many early- ...

Finding tumors early: Study says low-dose CT scanning can help detect lung cancer at treatable stage, reducing death rates.

Byline: Delthia Ricks Oct. 26-Routine screening of people at high risk of lung cancer with low-dose CT scanning can substantially drive down the death rate, according to a controversial new study led by a team of Manhattan researchers. Dr. Claudia Henschke, long an advocate of the spiral CT scan, ...

Summit women diagnosed later: Breast cancer found at more advanced stage, study finds.

Byline: Cheryl Powell Sep. 15-Summit County women are more likely than others statewide to be diagnosed with breast cancer at a late stage, when the disease is harder to treat and more likely to kill. And more than 30,000 Akron-area women 40 and older aren't getting mammograms or other screenings ...

Genentech Provides Update on Supplemental Biologics License Application for Adjuvant Herceptin in Early-Stage HER2-Positive Breast Cancer.

SOUTH SAN FRANCISCO, Calif., Aug. 11 /PRNewswire-FirstCall/ - Genentech, Inc. today announced that the U.S. Food and Drug Administrationhas notified the company that additional information recently requested during the review of the supplemental Biologics License Applicationfor ...

FDA approves first drug treatment for late-stage cervical cancer.

M2 PRESSWIRE-15 June 2006-US FDA: FDA approves first drug treatment for late-stage cervical cancer1994-2006 M2 COMMUNICATIONS LTD RDATE:15062006 The U.S. Food and Drug Administration has approved a combination of Hycamtinand cisplatin for use as the first drug ...

New Data Show Impressive Survival Benefit for Herceptin in Early-Stage HER2-Positive Breast Cancer.

BASEL, Switzerland, June 3 /PRNewswire/ - - Follow-up From the International HERA Trial Continues to Demonstrate Significant Patient Benefits From Herceptin New 23-month follow-up data from HERA, one of the largest breast cancer trials ever carried out, show that Herceptinfollowing ...

Clinical Trial Tests Effect of Ultrasound Waves on Early-Stage Prostate Cancer.

LYON, France, May 24 /PRNewswire-FirstCall/ - EDAP TMS S.A. announces the start of US Clinical Trial treatments. In a clinical trial at Duke University Medical Center, researchers are testing the use of high-intensity sound waves to treat early-stage prostate cancer. The nonsurgical technique, ...

Recruitment to Resume in Avastin International Phase III Trialin Early-Stage Colon Cancer.

SOUTH SAN FRANCISCO, Calif., May 23 /PRNewswire-FirstCall/ - Genentech today announced a decision by Roche, following a recommendation from an independent Data Safety Monitoring Board , to resume patient recruitment into AVANT, an international Phase III study of Avastin , ...

Test accurately predicted early-stage ovarian ca.(Disease/Disorder overview)

PASADENA, CALIF. - A panel of biomarker proteins developed by California researchers was able to diagnose early-stage mucinous ovarian cancer tumors with 100% sensitivity and specificity in a small study. In contrast, the biomarker CA 125 accurately predicted just 67% of malignant tumors in the ...

Intracel and FDA Agree on Pivotal Phase III Clinical Protocol for Colon Cancer Vaccine; OncoVAX Vaccine Designed to Prevent Tumor Recurrence in Stage II Colon Cancer Patients Following Surgical Tumor Removal.

FREDERICK, Md. - Intracel, a biopharmaceutical company developing and commercializing cancer vaccines and other immunotherapeutic products, announced today that it has reached agreement with the U.S. Food and Drug Administrationon a pivotal Phase III clinical protocol for its OncoVAX ...

Pattern of biomarkers detects early-stage ovarian cancer.

Pasadena, Calif. - Apanel of biomarker proteins developed by California researchers was able to diagnose early-stage mucinous ovarian cancer tumors with 100% sensitivity and specificity in a small study. In contrast, the biomarker CA 125 accurately predicted just 67% of malignant tumors in the ...

BioCurex Blood Test Detects Very Early Stages of Breast Cancer With High Specificity.

RICHMOND, British Columbia - BioCurex Inc.announced today that its RECAF blood test for cancer is able to detect very early stages of breast cancer with a high degree of accuracy. The study was blinded in that the actual diagnosis was not disclosed to BioCurex until after the ...

Med:Drug now available for early stage bowel cancer

AAP General News04-04-2006 Med:Drug now available for early stage bowel cancer EDS: Embargoed until 0600 AEST Tuesday, April 4 By Rosemary Desmond BRISBANE, April 4 AAP - Early stage bowel cancer patients can now be treated at home with the drug Xeloda instead of suffering through ...